Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-14 5:32 pm Sale | 2024-12-31 | 13G | Candel Therapeutics, Inc. CADL | Northpond Ventures, LP | 0 0.000% | -1,935,215 (Position Closed) | Filing History |
| 2025-02-14 4:14 pm Purchase | 2024-12-31 | 13G | Candel Therapeutics, Inc. CADL | BAKER BROS. ADVISORS LP | 2,981,983 6.800% | 2,981,983 (New Position) | Filing History |
| 2025-02-07 4:09 pm Sale | 2024-12-31 | 13G | Candel Therapeutics, Inc. CADL | CVI Investments, Inc. | 0 0.000% | -2,350,000 (Position Closed) | Filing History |
| 2025-02-07 10:18 am Purchase | 2025-01-31 | 13G | Candel Therapeutics, Inc. CADL | FMR LLC | 6,318,721 15.000% | 2,395,122 (+61.04%) | Filing History |
| 2025-02-07 10:03 am Purchase | 2024-12-31 | 13G | Candel Therapeutics, Inc. CADL | FMR LLC | 3,923,599 9.300% | 3,186,003 (+431.94%) | Filing History |
| 2024-12-17 12:30 pm Purchase | 2024-12-13 | 13G | Candel Therapeutics, Inc. CADL | CVI Investments, Inc. | 2,350,000 5.600% | 2,350,000 (New Position) | Filing History |
| 2023-02-09 09:59 am Sale | 2023-02-09 | 13G | Candel Therapeutics, Inc. CADL | FMR LLC | 737,596 2.552% | -1,525,246 (-67.40%) | Filing History |
| 2022-02-14 4:40 pm Purchase | 2021-12-31 | 13G | Candel Therapeutics, Inc. CADL | Northpond Ventures, LP | 1,935,215 6.700% | 1,935,215 (New Position) | Filing History |
| 2022-02-14 4:38 pm Purchase | 2021-07-29 | 13D | Candel Therapeutics, Inc. CADL | Manning Paul B | 4,073,316 13.600% | 4,073,316 (New Position) | Filing History |
| 2022-02-09 09:11 am Purchase | 2022-02-08 | 13G | Candel Therapeutics, Inc. CADL | FMR LLC | 2,262,842 7.887% | 2,262,842 (New Position) | Filing History |